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ABSTRACT
Autophagy may play a critical role in colon cancer stem cells (CCSCs)-related
cancer development. Here, we investigate whether accumulation of infection/injuryinduced CCSCs due to impaired autophagy influences colon cancer development
and progression. When Apc++ mice were infected with Citrobacter rodentium (CR;
109CFUs), we discovered presence of autophagosomes with increases in Beclin-1,
LC3B and p62 staining during crypt hyperplasia. Apc1638N/+ mice when infected
with CR or subjected to CR+AOM treatment, exhibited increased colon tumorigenesis
with elevated levels of Ki-67, β-catenin, EZH2 and CCSC marker Dclk1, respectively.
AOM/DSS treatment of Apc1638N/+ mice phenocopied CR+AOM treatment as
colonic tumors exhibited pronounced changes in Ki-67, EZH2 and Dclk1 accompanied
by infiltration of F4/80+ macrophages, CD3+ lymphocytes and CD3/β-catenin colocalization. Intestinal and colonic tumors also stained positive for migrating CSC
markers CD110 and CDCP1 wherein, colonic tumors additionally exhibited stromal
positivity. In tumors from CR-infected, CR+AOM or AOM/DSS-treated Apc1638N/+
mice and surgically-resected colon tumor/metastatic liver samples, significant
accumulation of p62 and it’s co-localization with LC3B and Dclk1 was evident.
ApcMin/+ mice when infected with CR and BLT1-/-;ApcMin/+ mice, exhibited similar colocalization of p62 with LC3B and Dclk1 within the tumors. Studies in HCT116
and SW480 cells further confirmed p62/Dclk1 co-localization and Chloroquin/LPSinduced increases in Dclk1 promoter activity. Thus, co-localization of p62 with
Dclk1 may hamper Dclk1’s elimination to impact colon cancer development and
progression.

www.oncotarget.com

2340

Oncotarget

INTRODUCTION

in host defense against Citrobacter rodentium (CR)
infection and in the regulation of infectious colitis [4].
However, the mechanistic role of CR-induced autophagy
in regulating cellular proliferation and neoplastic
transformation underlying tumor development is not
well understood. In response to CR infection, electron
microscopy revealed significant increase in autophagic
vacuolation and autophagic vesicles were widespread at
12 days post-infection in the Apc++ NIH:Swiss (Figure
1A, 1B). During measurement of Beclin-1, LC3B and
p62 kinetics in Apc++ NIH:Swiss mice, the staining
intensities for these proteins increased significantly at
day 12 and subsequently declined at days 20, 27 and
34 post-infection (Figure 1C; Supplementary Figure
1A). In addition to NIH:Swiss outbred mice, colons
of C57Bl/6 inbred mice also exhibited elevated levels
of Beclin-1, LC3B and p62 staining in response to CR
infection (Supplementary Figure 1B-1D). The kinetics
for Beclin-1 and LC-3B were similar to NIH:Swiss with
peak responses between 9-12 days while p62 remained
elevated even at day 19 post-infection (Supplementary
Figure 1D). Interestingly, TUNEL assay, a measure
of apoptosis, did not reveal any significant change
in response to infection (Figure 1D) suggesting that
the apoptotic pathway may not be underpinning CR
pathogenesis.
Since dysregulation of autophagy is not only
associated with microbial infections but with numerous
disease manifestations including cancer, we began
to systematically look at murine models of colon
cancer and whether autophagy played a role in tumor
development and/or progression. Using the Apc1638N/+
model that mimics familial adenomatous polyposis, we
observed CR to minimally impact tumorigenesis in the
small intestine as is revealed in Figure 2 consistent with
CR being a colonic pathogen. Indeed, in response to CR
infection, colons displayed significant increase in tumor
development at 90-120 days post-infection and these
tumors were highly proliferative as was revealed by Ki67 staining (Figure 2A). Interestingly, both intestinal
and colonic tumors exhibited elevated levels of EZH2
(Figure 2B) and β-catenin (Supplementary Figure 1E)
staining, respectively. WIF-1 staining on the other hand,
while positive in untreated intestine/colon sections,
were undetectable in CR-treated tumors (Figure 2B).
These results are consistent with our previous reports
[10]. Since cancer stem cells (CSCs), which comprise
a small proportion of total cancer cells, have special
capacities for self-renewal, differentiation and tumor
formation and Dclk1 is a validated marker of CSCs, we
next stained tumors from either organ with antibody for
Dclk1. As is revealed in Figure 2C and Supplementary
Figure 2, we discovered dramatic increases in Dclk1
staining in sections prepared from both intestinal and
colonic tumors consistent with Dclk1’s role in tumor
development [16, 17].

Autophagy is a cellular mechanism for the
degradation and recycling of cellular components via the
lysosomal pathway and is important for the survival and
homeostasis [1]. It is well established that autophagy is
also used as a defense mechanism to combat infection
of host cells by intracellular pathogens [2, 3]. However,
several of these pathogens have developed mechanisms
to bypass the autophagic response to promote their
survival and proliferation and simultaneously affect
the host inflammatory responses. Previous studies have
demonstrated that autophagy in intestinal epithelial
cells plays an important role in host defense against
Citrobacter rodentium (CR) infection and the regulation
of CR-induced infectious colitis [4]. Investigations
in our laboratory have utilized CR-infection-induced
murine model that exhibits increased proliferation and
an expanded proliferative zone in the mouse distal
colon with associated injury or significant histological
inflammation depending upon the genetic background
[5–10]. We have also established that crypt hyperplasia
exhibits both functional and molecular changes typical
of the earliest stages of neoplastic transformation [5–10].
Yet, a systematic role for infection or chemical stressors
(e.g., AOM or DSS) or a combination thereof, on either
autophagy induction or autophagy-related impairment
that leads to pro-survival mechanisms culminating in
tumorigenesis, has not been thoroughly investigated.
p62 is a multifunctional adapter protein implicated
in selective autophagy, cell signaling pathways and
tumorigenesis [11]. Autophagy is activated in cancer cells
in response to various anticancer therapies and modulation
of p62 stability by autophagy can play diverse roles in
tumorigenesis [11]. In addition, p62 has been labeled
as a major pro-oncogenic regulator of several important
signaling pathways including NF-κB, p44/42 MAPK and
mTOR [12, 13]. Cancer stem cells (CSCs) have special
capacities for self-renewal, differentiation and tumor
formation and are regarded as the major cause of failure in
anticancer therapy, such as chemo-and/or radioresistance,
tumor recurrence and metastasis [12, 14]. Autophagy may
play a dual role in CSCs-related resistance to anticancer
therapy [15]. However, the contribution of autophagy in
the physiology of CSCs appears complex and is not yet
fully elucidated. In the current report, we examined the
components of the autophagic machinery and a probable
link between autophagy and cancer stemness based on the
hypothesis that infection and/or injury-related alterations
in autophagy may hamper CSCs elimination which may
lead to colon cancer development and/or progression.

RESULTS
Previous studies have demonstrated that autophagy
in intestinal epithelial cells plays an important role
www.oncotarget.com
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Since Apc1638N/+ mice have previously been
shown to exhibit metastatic potential [13], we next
investigated the probability of a mutagenic insult
when combined with CR infection to expedite tumor

progression. As is revealed in Figure 3, CR+AOM
treatment did not necessarily have an additive effect on
tumorigenesis in either the intestine or the colon compared
to CR infection alone although the staining intensities for

Figure 1: Evidence of basal autophagy in response to CR infection. (A and B) Electron microscopy in the distal colons of

uninfected (N) or mice infected with CR at days 6, 12, 20, 27 and 34, showing presence of CR at the luminal surface and autophagosomes/
autophagic vesicles AV; arrows). Both microvilli and goblet cells can also be seen. (C) Immunofluorescent staining of N-D34 samples
with antibodies for p62 and LC3B, respectively. Scale bar = 150μm; n = 3 independent experiments. (D) Immunohistochemical labeling of
TUNEL positive cells within the crypt of N-D34 mouse distal colons. Scale bar = 100μm; n = 3 independent experiments.
www.oncotarget.com

2342

Oncotarget

Figure 2: CR infection influences tumorigenesis. (A) Paraffin-embedded sections prepared from the intestinal or colonic tumors

isolated from uninfected (N) or CR infected Apc1638N/+ mice were subjected to H&E staining for gross morphology or Ki-67 staining to
detect cell proliferation (Scale bar = 75 μm; n = 3 independent experiments). (B and C) Immunofluorescent staining of uninfected (Un) or
CR infected (CR) intestinal or colonic tumors with antibodies for EZH2 and WIF-1 (B) and Dclk1 (C). Scale bars = 150μm (b); 250μm (c);
n = 3 independent experiments.
www.oncotarget.com
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need to breed either Apc1638N/+ or ApcMin/+ mice with
Beclin-1 or Atg7 knockout mice to definitively assess the
impact of autophagy on colon cancer development, for
the current study, we investigated the effect of Atg7 or
Beclin-1 knockdown on Dclk1 promoter-reporter activity.
As is depicted in Supplementary Figure 3B and 3C,
siRNAs to either ATG7 or Beclin-1: i) reduced ATG7 and
Beclin-1 protein levels (Supplementary Figure 3B) and
ii) significantly inhibited Dclk1 reporter activity without
necessarily impacting Dclk1 protein levels (Supplementary
Figure 3C, 3B) suggesting that autophagy-related proteins
and Dclk1 may functionally interact to influence Dclk1’s
CSC capabilities.
Chronic intestinal inflammation is a risk factor for
development of colon cancer and azoxymethane (AOM)
and dextran sodium sulfate (DSS) combination has been
shown to model colitis-associated colon cancer. Since
defects in autophagy have been reported in inflammatory
bowel diseases and p62 has been shown to be upregulated
in ulcerative colitis patients [22], we wanted to investigate
if CR/AOM-induced changes in autophagy could be
phenocopied in Apc1638N/+ mice receiving AOM/
DSS. As is depicted in Figure 5, both small intestine and
colon tumors responded very aggressively to either DSS
or AOM/DSS with colonic tumors exhibiting gradual
increases in Ki-67, EZH2 and Dclk1 staining in treated
samples compared to untreated controls. Dclk1 again
co-stained with AcTub (Supplementary Figure 4). These
tumors were also highly inflamed as was revealed by
infiltration of F4/80+ macrophages (Figure 6, upper
panel) and CD3+ lymphocytes (Figure 6, upper middle
panel). Interestingly, CD3 co-localized with β-catenin in
these tumors indicating contribution of Wnt signaling in
the tumorigenic process (Figure 6, middle two panels).
Both intestinal and colonic tumors also stained positive for
migrating cancer stem cell markers CD110 and CDCP1
(Figure 6, lower panel) and Lgr5 (Supplementary Figure
5), respectively. Colonic tumors additionally exhibited
stromal positivity suggesting local spread (Figure 6, lower
panel).
Further investigation of tumors from AOM/
DSS-treated Apc1638N/+ mice revealed significant
colocalization of p62 with Dclk1 (Figure 7A). To ensure
that changes in p62 were indeed due to autophagy, we
examined co-localization of p62 with LC3B. As expected,
the staining for p62 overlapped with that of LC3B in
both the intestinal and the colonic tumors, respectively
(Supplementary Figure 6A). We also confirmed presence
of autophagic vesicles within the tumors via electron
microscopy (Supplementary Figure 6B) and relative
levels of Dclk1, p62 and LC3B via Western blotting
(Supplementary Figure 6C). These findings were further
validated in ApcMin/+ mice infected with CR (Figure
7B) wherein, Dclk1/p62 co-localization was evident
along with Dclk1’s co-localization with β-catenin and
EZH2. Presence of autophagic vesicles was confirmed

Ki-67 and EZH2 were higher in CR, AOM and CR+AOM
groups compared to untreated controls. Interestingly,
AOM treatment alone induced significant Dclk1 staining
in the intestinal tumors and more so in the colon. Since
Dclk1 as a microtubule regulator marks a morphologically
distinct and functionally unique population of cancerinitiating cells with molecular features of gastrointestinal
tuft cells [18], we co-stained the sections with antibodies
for Acetylated Tubulin (AcTub) and Dclk1, respectively.
As is revealed in Supplementary Figure 3A, the staining
for AcTub was virtually identical with that of Dclk1
suggesting Dclk1/AcTub to represent the CSC population.
These results underscore the complexity of tumorigenesis
in Apc1638N/+ mice wherein, both infection and chemical
stressors are equally capable of inducing CSCs.
Since autophagy represents a pro-survival
mechanism implemented by neoplastic cells in response
to stressful stimuli and Dclk1’s expression as a marker of
CCSCs, is associated with cancer growth, EMT and tumor
metastasis, we next explored probable interaction between
p62 and Dclk1+ CCSCs in vivo and in cell lines. As is
depicted in Figure 4, both intestinal and colonic tumors
exhibited significant co-localization of Dclk1 with p62.
Colonic tumors in particular, responded positively to both
CR and CR+AOM wherein, Dclk1 and p62 co-localization
was clearly evident (Figure 4, Intestine & Colon panels).
As proof of concept, we utilized two validated colon
cancer cell lines to confirm Dclk1’s co-localization with
p62. In both HCT116 and SW480 cells treated with either
CQ (30μM) to block autophagy and promote efficient
autophagic flux or LPS to mimic Citrobacter rodentium
(CR) infection, we discovered significant co-localization
of Dclk1 with p62 compared to untreated controls (Figure
4, middle panels). Since the level of p62 can also be
modulated independent of autophagy, we employed
additional methods to assess autophagic flux wherein
we monitored LC3 turnover [19, 20]. In the presence of
CQ, LC3-II accumulated indicating efficient autophagic
flux and co-localized with p62 (Figure 4, middle, lower
right panels). The enhanced accumulation of autophagic
vesicles in the presence of either CQ or LPS was further
confirmed by electron microscopy (Figure 4, lower left
panel). The expression levels of LC3-I/II, p62 and Dclk1
in HCT116 cells when treated with CQ and LPS increased
dose dependently as was revealed by Western blotting
(Figure 4, lower middle panels). Since long (Dclk1-L)
and short (Dclk1-S) isoforms of Dclk1, regulated by αand β-promoters, have been recently described [21], we
next cloned the two promoters and performed a promoterreporter activity. As is shown in Figure 4, both CQ and
LPS significantly increased the Dclk1-L reporter activity
independently of their dosages. Interestingly, CQ at 30μg
failed to influence Dclk1-S activity. At 60μg however,
a >2.0-fold increase in reporter activity was recorded.
Similar responses were seen with varying dosages of LPS
(Figure 4, graphs, lower right). Since there is an unmet
www.oncotarget.com

2344

Oncotarget

Figure 3: Measuring the combined effect of infection and mutagenic injury on tumorigenesis. Paraffin-embedded sections

prepared from the intestinal or colonic tumors isolated from uninfected (Un), CR infected (CR), AOM-treated or CR+AOM-treated
Apc1638N/+ mice were subjected to H&E staining for gross morphology or Ki-67 staining to detect cell proliferation. Sections were
also immuno-stained with antibodies for EZH2 and Dclk1, respectively. DAPI was used as nuclear stain. Scale bars = 150-250μm; n = 3
independent experiments.
www.oncotarget.com
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via electron microscopy (Figure 7C) and relative levels of
Dclk1, p62 and LC3-I/II were validated through Western
blotting (Figure 7D). In BLT1-/-;ApcMin/+ mice that exhibit
exaggerated tumorigenesis in the intestine and particularly
in the colon 10, we found similar increases in Dclk1 and

its co-localization with both Atg7 and p62, respectively
(Supplementary Figure 7A). Since inflammation drives the
tumorigenic process in these mice, we also stained sections
from these mice with antibody for CD3. As is depicted
in Supplementary Figure 7B, we discovered increases

Figure 4: Evidence of altered autophagy in the intestinal/colon tumors. Paraffin-embedded sections prepared from the intestinal

or colonic (upper panels) tumors isolated from uninfected (Un), CR infected (CR), AOM-treated or CR+AOM-treated Apc1638N/+ mice
were subjected to co-localization studies with antibodies for p62 and Dclk1, respectively. DAPI was used as nuclear stain. Co-localization
of p62 and Dclk1 appears as yellow/orange puncta in the merged images. Scale bars = 150-250μm; n = 3 independent experiments. Middle
panel. In vitro evidence of autophagy flux.HCT116 and SW480 cells treated for 24hr with either Chloroquin (CQ, 30μM) to block autophagy
and promote efficient autophagic flux or LPS to mimic CR infection. Cells were processed and co-localization of p62 with Dclk1 and p62
with LC3B was evaluated. DAPI was used as nuclear stain (n = 3 independent experiments). Co-localization of p62 and Dclk1 appears
as yellow/orange puncta in the merged images. Lower panel. Left:Presence or absence of autophagic vesicles was further confirmed via
electron microscopy wherein, the effect of both autophagy inhibitor CQ or LPS was examined (n = 3 independent experiments). Middle:
Western blotting revealed a dose-dependent increase in Dclk1, LC3-II and p62, respectively. β-Actin and H3 were used as loading controls.
Right: Dclk1 promoter assay. HCT116 cells transfected with Dclk1-L or Dclk1-S reporters were either untreated or treated with varying
dosages of CQ or LPS followed by measurement of reporter activity (*p-values<0.05 vs control; n=3 independent experiments).
www.oncotarget.com
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in CD3 and its co-localization with β-catenin similar to
the staining pattern seen with AOM/DSS (see Figure 6).
Changes in Dclk1, p62, LC3-I/II and EZH2 were further
validated via Western blotting (Supplementary Figure 7C).

Prior studies have shown that a subset of Dclk1positive CSCs survive due to autophagy in response to
curcumin [23] and that increased Dclk1 correlates with
the malignant status and poor outcome in malignant

Figure 5: Measuring the combined effect of DSS and AOM+DSS on tumorigenesis. Paraffin-embedded sections prepared

from the intestinal or colonic tumors isolated from untreated (Un), DSS-treated or AOM+DSS-treated Apc1638N/+ mice were subjected to
H&E (A), Ki-67 (B), EZH2 (C) and Dclk1 (D) staining, respectively. A montage of three representative images for each group is shown.
DAPI was used as nuclear stain. Scale bars = 150-250μm; n = 3 independent experiments.
www.oncotarget.com
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tumors [24]. We next examined surgical samples from a
patient with multiple tumors in the colon and metastasis
to the liver. As is shown in Figure 7E and Supplementary
Figure 7D and 7E, both the colon tumors and liver mets
exhibited significant co-localization of Dclk1 with p62
suggesting that p62/Dclk1 interaction may be relevant in
the pathogenesis of tumor development and progression.

basal autophagy. Moreover, CR infection when combined
with AOM exhibit significant increase in Dclk1+ CCSCs
that co-localizes with autophagy-related protein p62.
We further provide evidence of p62/Dclk1 interaction in
AOM/DSS and BLT1-/-;ApcMin/+ models of colon cancer
as well as in surgical samples of a colon cancer patient
with liver metastasis. These findings strongly suggest
that p62/Dclk1 interaction may contribute towards tumor
development and progression in the colon.
Autophagy plays a significant role in controlling
the pathogenesis of infectious diseases by regulating
processes related to pathogen clearance, lymphocyte
development, antigen presentation and immunoglobulin
production etc., [2, 3]. Impaired autophagy contributes
to oxidative stress, genomic instability, chronic tissue
damage, inflammation and tumorigenesis, and is involved
in aberrant bacterial clearance and immune priming.
Salmonella Typhimurium for example, interferes with
host responses via delivery of the effector proteins into
cytosol to promote its survival and proliferation [3]. We

DISCUSSION
Autophagy, a fundamental cellular process
important for survival and homeostasis, is also used as
a defense mechanism to combat infection [2]. Pathogens
have however developed mechanisms to avoid the
autophagic response to prolong their survival. Previous
studies have demonstrated that autophagy in intestinal
epithelial cells plays an important role in host defense
against Citrobacter rodentium (CR) infection and the
regulation of CR-induced infectious colitis [4]. In this
study, we provide evidence that CR infection induces

Figure 6: Recruitment of immune cells and evidence of local spread. Paraffin-embedded sections prepared from the intestinal or
colonic tumors isolated from untreated (Un), DSS-treated or AOM+DSS-treated Apc1638N/+ mice were subjected to F4/80 (upper panel),
CD3/β-catenin co-localization (middle panel) and CD110 and CDCP1 (lower panel) staining, respectively. DAPI was used as nuclear stain.
Scale bars = 150-250μm; n = 3 independent experiments.
www.oncotarget.com
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Figure 7: Epithelial injury promotes accumulation of p62. Paraffin-embedded sections prepared from the intestinal or colonic
tumors isolated from untreated (Un), DSS-treated or AOM+DSS-treated Apc1638N/+ (A) or CR-infected ApcMin/+ (B) mice were costained with antibodies for p62 and Dclk1 (A, B), Dclk1 and β-catenin or Dclk1 and EZH2, respectively (B). Inset in B shows merged
images of the p62/Dclk1 puncta. Scale bars = 150-250μm; n = 3 independent experiments. (C) Electron microscopy showing presence of
autophagic vesicles in the CR-infected but not uninfected ApcMin/+ mouse distal colonic fragments (2μm sections; arrows; n = 3 independent
experiments). (D) Western blotting to detect changes in Dclk1, p62, LC3B and EZH2, respectively. GAPDH and β-Actin were used
as loading controls. (E) Evidence of p62 and Dclk1 co-localization in surgically resected colon cancer samples with metastasis to the
liver. Paraffin-embedded sections prepared from surgically resected colon tumors and liver mets were co-stained with antibodies for p62
and Dclk1 and p62 and LC3B, respectively. Representative merged images are shown with an H&E stained section showing the gross
morphology. Scale bars = 450μm.
www.oncotarget.com
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they are being bred to ApcMin/+ mice to definitively
link Dclk1 in colon cancer development and progression
in response to CR infection.
Intriguingly, p62 seems to co-localize with Dclk1
as a punctate staining at the plasma membrane while
occasional co-localization could be seen within the
nucleus. Since Dclk1 exists in a membrane-bound
long (Dclk1-L) and membrane/nuclear localized short
(Dclk1-S) forms consistent with presence of both
transcripts coded for by α- and β-promoters respectively
[24], our findings suggest that both isoforms of Dclk1
are probably involved in the tumorigenic process. The
increases in Dclk1-L and Dclk1-S promoter activities
following treatment with either autophagy inhibitor
CQ or LPS further support our conclusion. Finally,
staining of the surgically resected tumors from patients
with colon cancer and metastasis to the liver clearly
demonstrated co-localization of p62/Dclk1 puncta
both at the plasma membrane and within the nucleus
suggesting involvement of both isoforms. In an elegant
study, Kantara et al., [23] previously described that a
subset of Dclk1-positive CSCs survive due to autophagy
in response to curcumin. In line with this observation,
our findings provide a more comprehensive look into the
complexity of Dclk1 regulation during tumorigenesis and
suggest that Dclk1+ cells may survive due to impaired
autophagy. Since it is generally believed that autophagy
contributes to stemness maintenance of CSCs [15] and
increases in Dclk1 correlates with the malignant status
and poor outcome in malignant tumors [24], our studies
provide a rationale to capture these interactions early
through small molecule inhibitor-based Dclk1 targeting
to block Dclk1 from interacting with p62 as a strategy to
prevent or treat colon cancer.

demonstrate significant induction of basal autophagy
with accumulation of Beclin-1, LC3B and p62 at peak
crypt hyperplasia. Interestingly, there was no parallel
increase in apoptosis of crypt epithelial cells. In a recent
study, it was revealed that activation of autophagy
results in inhibition of apoptosis [25]. Similarly, ectopic
overexpression of Cdx1 in CD44+CD24+p53wt stem
cells induced LC3-II and inhibited cell death from
paclitaxel treatment suggesting that activation of
autophagy inhibited apoptosis [26]. Since we have shown
previously that activation of Wnt/β-catenin, Notch and
NF-κB pathways regulate CR-induced crypt hyperplasia
[5-10, 27, 28], it is tempting to speculate that induction of
basal autophagy in response to CR infection is required
to inhibit apoptosis and to promote crypt hyperplasia
reminiscent of earliest stages of neoplastic changes
associated with colon cancer [9, 10]. This speculation is
not unprecedented since an elegant study recently showed
that Fusobacterium nucleatum-induced autophagy
inhibited apoptosis leading to recurrence of colorectal
cancer and poor outcomes [29].
Colon cancer stem cells have been identified
as one of the major contributors to resistance of
colon cancer to chemotherapy [30]. Doublecortinlike kinase 1 (Dclk1) is a validated CSC marker in
the gastrointestinal tract [18, 31]. We have previously
shown significant changes in Dclk1 expression during
crypt hyperplasia and tumorigenesis [9]. Using various
models of colon carcinogenesis, we now present
evidence of significant upregulation of Dclk1 within the
tumors and that Dclk1 co-localizes with p62. Aberrant
autophagy associated with p62 dysfunction is involved
in the pathogenesis of human diseases. Indeed, aberrant
accumulation of p62-positive aggregated structures
has been detected in patients with liver disorders,
tumors and neurodegenerative diseases [11, 32]. p62
is also a pathogenic target of 5q copy number gains
in kidney cancer [33]. In colon cancer patients, a
positive correlation has been reported between tumor
progression and p62 expression [34] in accordance with
p62’s role as a significant contributor to tumorigenesis
[35]. Interestingly, p62 levels positively correlated
with Wnt regulator Dvl2 in late stage tumors indicating
that impairment of autophagy may contribute towards
aberrant Wnt activation [34]. Similarly, stimulation of
tumor growth by p62 accumulation in FIP200 (FAK
family-interacting protein of 200 kDa)-null tumors was
associated with the activation of NF-κB pathway [36].
Coincidentally, we have previously reported activation
of both Wnt and NF-κB pathways in models of CRinduced crypt hyperplasia and tumorigenesis (5-10, 15,
16). Thus, Dclk1 accumulation and its co-localization
with p62 that we see within the tumors does not seem to
be merely a histologic marker. Yet, whether it directly
contributes towards tumor growth and progression is
being elucidated in colon-specific Dclk1 knockouts as
www.oncotarget.com

MATERIALS AND METHODS
Animals
NIH:Swiss, C57Bl/6 and ApcMin/+ mice were
procured from Envigo and Jackson Laboratory,
respectively. Apc1638N/+ mice were initially acquired
from NCI Repository and subsequently bred in-house to
reach the numbers needed for each experiment. BLT-/-;
ApcMin+ mice were generated as described [10]. All the mice
were maintained in a specific pathogen-free (including
helicobacter and parvovirus) environment and generally
used between 5 and 6 weeks of age. As control groups,
either littermates or WT mice of identical background were
used. This study was carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
All protocols were approved by the Institutional Animal
Care and Use Committee of the University of Kansas
Medical Center.
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Treatments

using Histostain-SP kit (Invitrogen, Carlsbad, CA, USA)
and following their instructions. Briefly, deparaffinized
sections were boiled for 20 minutes in 0.01 M citrate
buffer at pH 6.0 for epitope retrieval. The sections were
then blocked for 10 minutes using a serum blocking
solution. Sections were incubated for 1 hour at 4°C with
primary antibodies (described below). After 3 washings
of 5 minute each in PBS, sections were subsequently
incubated with biotinylated secondary antibodies for 10
minutes, followed by 10-minute incubation with enzyme
streptavidin-peroxidase conjugate. This was followed
by 3-5 minute incubation with DAB solution containing
diaminobenzidine (DAB) chromogen for developing
and 0.6% H2O2 to inhibit endogenous peroxidase
activity. The sections were finally counterstained
with hematoxylin and dehydrated with graded series
of ethanol and cleared in xylene. After staining, the
sections were mounted with mounting medium and
images were obtained and analyzed with a Nikon i80
microscope.

Colonic crypt cell hyperplasia was induced in
the mice by oral inoculation with a 16-h culture of C.
rodentium (biotype 4280, ATCC, 108CFUs) identified
as pink colonies on MacConkey agar, as previously
described [5-10, 27, 28]. Biotype 4280 is a unique mousespecific strain that adheres to mature surface colonocytes
within the distal colon to induce histopathological changes
known as attaching and effacing lesions [37]. Adherent
bacteria were assayed using RT-PCR for bacterial intimin
in whole tissue extracts [38]. Age- and sex-matched
control mice received sterile culture medium only. For
AOM and DSS studies, 5-6 weeks old Apc1638N/+
mice on day 0 were injected intraperitoneally (IP) with
10 mg/kg of AOM working solution (1 mg/ml in isotonic
saline, diluted from 10 mg/ml stock solution in dH2O
kept at -20 0C). A 2.5% (2.5 g/100 ml) DSS solution in
distilled water was readied and passed through a 0.22
μm cellulose acetate filter by vacuum. On day 7, DSS
solution was supplied to mice in their drinking water.
Approximately 250 ml/cage was needed every time new
DSS was provided for a maximum of 5 mice/cage. To
provide a continuous supply of DSS for seven days,
DSS solution was replaced in clean bottles three times
(every 2-3 days) during this period. On day 14, cages
were switched back to standard drinking water for the
duration of the experiment. All untreated or treated mice
were euthanized at specified time points. To examine the
presence or absence of autophagy flux in vitro, we used
HCT116 and SW480 colon cancer cells and treated them
with either Chloroquin (CQ; 30 or 60μM) or LPS (15 or
25μg/ml) (Sigma-Aldrich, St. Louis, MO, USA) for 24hrs
followed by measurement of autophagy-related markers
via immunostaining and Western blotting.

Immunoflourescence
After dewaxing and rehydration, tissue sections
were incubated with relevant primary antibody overnight
at 4°C. Antibodies used were rabbit anti-DCLK1 (1:200,
ab31704, ab109029) from Abcam (Cambridge, UK),
mouse anti-p62/SQSTM1 (1:300, H00008878-M01),
rabbit anti-Beclin1 (1:200, NB500-249), anti-LC3B
(1:250, NB100-2220) from Novus Biologicals (Littleton,
CO, USA). Anti-CDCP1 from Boster, (Pleasanton,
CA, USA), CD110 from LSBio, (Seattle, WA, USA)
and Anti-F4/80 (Thermo Fisher). Anti-β-catenin, antCD3 from BD Biosciences (San Jose, CA, USA), antiEZH2, anti-H3 were from Cell Signaling Technology
(Danvers, MA, USA) and anti-WIF1 from Santa Cruz
Technology (Santa Cruz, CA, USA). After incubation, the
slides were washed 3 times in PBS for 5 min each. The
secondary antibody staining was performed by covering
the tissue sections with a 1:1000 dilution of Alexa Fluor
488 / 594 conjugated goat anti-rabbit / anti-mouse IgG
antibody (original concentration: 2 mg/ml; (Thermo
Fisher Scientific, Waltham, MA, USA) in blocking
buffer and the sections were incubated for 1 hour at room
temperature in dark. The excess liquid was blotted away
and the sections were rinsed twice for 5 min each using
PBS. Next, the sections were stained for 5 min at room
temperature in dark using a 10 mg/ml of DAPI solution
diluted in 1x PBS (Sigma-Aldrich, St. Louis, MO, USA).
The sections were then rinsed with Milli-Q water and
blotted dry. Finally, the sections were covered with
ProLong Gold Antifade Mounting media (Invitrogen,
Carlsbad, CA, USA), covered with coverslips and the
edges of the coverslips sealed with nail polish. The slides
were kept at room temperature in dark for at least 24 h
and then visualized by Nikon i80 upright fluorescence
microscope.

Histology
Colon tissues/tumors were freshly harvested from
mice and fixed with 10% neutral buffered formalin prior to
paraffin embedding. De-identified and surgically resected
colon tumors and liver mets were likewise fixed in 10%
neutral buffered formalin prior to paraffin embedding.
Paraffin-embedded sections (4 μm) were stained with
Hematoxylin and Eosin for morphology using standard
techniques. Goblet cells were stained with PAS (Richard
-Allan Scientific) or Alcian blue (Thermo Scientific) and
counterstained with Nuclear Fast Red (Sigma-Aldrich).
The pictures were obtained with a Nikon i80 microscope
(Nikon Instruments, Melville, NY, USA).

Immunohistochemistry
Paraffin embedded sections were dewaxed with
xylene and rehydrated in graded series of ethanol. Tissue
sections were then washed with PBS before starting
staining procedure. Immunohistochemistry was done
www.oncotarget.com
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Quantitative Reverse-Transcriptase PCR
RNA was isolated using TRIzol (Life Technologies,
Grand Island, NY, USA) and converted to cDNA using the
High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems, Foster City, CA, USA). The concentration of
RNA was measured using a spectrophotometer (Nanodrop
2000, Thermo Fisher Scientific). Gene expression was
assessed using Jumpstart Taq Polymerase (Sigma-Aldrich)
and SYBR Green nucleic acid stain (Life Technologies).
Threshold crossing values for each gene were normalized
to glyceraldehyde phosphate dehydrogenase (GAPDH)
gene expression. mRNA expression was then normalized
to fold change relative to controls.
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